Xenter Closes Series B Financing, Raising $58.25 Million to Accelerate Commercial Expansion of its TechMed™ Platform

Xenter, Inc., a healthcare technology company specializing in the development of innovative medical devices and data solutions, has successfully completed its Series B financing, securing $58.25 million in funding. The financing round closed on June 30, 2026, and aims to support the commercial launch of Xenter's TechMed™ platform and the ongoing development of its proprietary technologies. This significant capital infusion reflects strong investor confidence in Xenter's vision to revolutionize healthcare data capture and utilization.

The Series B round attracted participation from existing shareholders, family offices, and specialized healthcare investors, all of whom share a commitment to transforming the healthcare landscape. The funds raised will facilitate the commercial rollout of Xenter's diagnostics business unit and support the clinical testing of its Guru™ dual sensor physiology guidewire, particularly in Transcatheter Aortic Valve Replacement (TAVR) procedures. The financing will also enable the expansion of manufacturing capabilities, clinical and regulatory initiatives, and the acceleration of Xenter's integrated TechMed platform.

Founded in 2020 by Richard J. Linder, Xenter positions itself at the intersection of medical devices, data infrastructure, and artificial intelligence. The company has developed a healthcare intelligence platform that captures Physical Intelligence™ (PI) data through its XenFi™ wireless ecosystem. This platform aims to create a seamless integration of medical devices and diagnostics, ultimately enhancing clinical decision-making and improving patient outcomes. The appointment of Linda Vega to the Board of Directors further strengthens the company's leadership, bringing extensive experience in finance, corporate governance, and strategic capital planning.

The healthcare technology sector is experiencing rapid growth, driven by increasing demand for innovative solutions that enhance patient care and operational efficiency. As healthcare systems worldwide grapple with fragmented information and disconnected devices, Xenter's integrated approach offers a compelling solution. By focusing on real-time data capture and connectivity, Xenter aims to address critical challenges in the healthcare industry, including data silos and inefficient workflows.

The successful completion of this funding round positions Xenter to capitalize on the growing trend toward integrated healthcare solutions. As the company prepares for its commercial launch, it is well-positioned to play a pivotal role in the evolution of healthcare technologies. The broader market outlook suggests that as healthcare providers increasingly seek to leverage data-driven insights, companies like Xenter will be at the forefront of driving innovation and improving patient outcomes through advanced technology solutions.